Twitter Chat

Age-Related Macular Degeneration and the AREDS and AREDS2 Results

Thursday, July 18, 2013

2:00 - 3:00 p.m. ET

View the archived Twitter chat on Age-Related Macular Degeneration and the AREDS and AREDS2 Results

In the United States, advanced age-related macular degeneration (AMD) is a leading cause of blindness. About 2 million Americans are affected by late AMD, and 8 million more are at risk. Late AMD can be characterized by advanced geographic atrophy or neovascularization. The National Eye Institute has conducted two multi-year studies to determine whether certain nutritional supplements are useful for AMD. These Age-Related Eye Disease Studies (AREDS and AREDS2) have led to new insights into how patients can slow macular degeneration from reaching its late stage.

The National Eye Institute invites you to join us for our first Twitter Chat. NEI Deputy Clinical Director Dr. Emily Chew and other experts will "discuss" who can benefit from the AREDS supplements.

You may follow the stream of tweets at @NatEyeInstitute (http://Twitter.com/NatEyeInstitute) or at http://twubs.com/NEIChat. We will be using the hashtag #NEIChat.

For more information, please contact Kym Collins-Lee, kcl@nei.nih.gov.